International Conference on Cancer Care and Cure - Series II

May 06

Add to My Calendar Time: 08:30 AM - 06:30 PM

May 06, 2019 09:00 AM May 07, 2019 06:30 PM Kuala Lumpur, Malaysia International Conference on Cancer Care and Cure - Series II Kuala Lumpur, Malaysia Clyto Access cancerconference@clytoconferences.com true MM/DD/YYYY

Sessions - Cancer Conference 2019

Cancer:

Cancers are a large family of diseases that involve abnormal cell growth with the potential to invade or spread to other parts of the body. They form a subset of tumors. A tumor is a gathering of cells that have experienced unregulated development and will frequently form mass or lump, however might be diffused appropriately. Symptoms may include cough or pneumonia, narrowing of the esophagus, making it difficult or painful to swallow and narrowing or blockages in the bowel, affecting bowel habits and produces observable lumps, anemia or rectal bleeding and also includes weight loss, fever, excessive fatigue and changes to the skin.

Track: 1 Oncology

Oncology is the study of tumor. An oncologist is a specialist who treats cancer. More often than not, an oncologist deals with care and treatment once he or she is resolved to have malignancy. A restorative oncology is branch that deal with the treatment of cancer using chemotherapy or distinctive drugs, for instance, directed treatment. Atomic oncology is the investigation of science of malignancy and tumor cell at its sub-atomic cell.

Track: 2 Hematologic Oncology

Hematologic oncology is determination, treatment and anticipation of blood diseases (hematology) and cancer (oncology) and research into them. Hematologic oncology incorporates such diseases as iron inadequacy anemia, hemophilia, sickle cell disease, the thalassemia, leukemia and lymphomas, and in addition to these there are cancers of different organs. Tumors of the hematopoietic and lymphoid tissues or hematopoietic and lymphoid tissues are tumors that influence the blood, bone marrow, lymph, and lymphatic system. Plasma cell dyscrasias are scatters of the plasma cells. Plasma cell dyscrasias are created because of strange multiplication of a monoclonal population of plasma cells that might possibly discharge recognizable levels of a monoclonal immunoglobulin or immunoglobulin part (Para protein or M protein). Interminable lymphocytic leukemia (CLL) is a sort of tumor of the blood and bone marrow - the supple tissue inside bones where platelets are made. Myelodysplastic or myeloproliferative neoplasms are a gathering of ailments in which the bone marrow makes excessively numerous white platelets. Both Hodgkin's lymphoma and lymphoma are lymphomas, a sort of tumor that starts in a subset of white platelets called lymphocytes.

Track: 3 Clinical Oncology

Clinical Oncology incorporates Medical Oncology (MO), Surgical Oncology (SO), Gynecologic Oncology, and Hematologic Malignancies. Medical oncology conveys the consequences of clinical and test examine in oncology and hematology, especially with trial therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist represents considerable authority in the evacuation of the tumors and encompassing tissue amid an operation. A surgical additionally performs biopsies (the evacuation of a little measure of tissue for examination under a magnifying instrument). Hematologic malignancies are types of growth that start in the cells of blood-shaping tissue, for example, the bone marrow, or in the cells of the safe framework. Werner Syndrome (WS), otherwise called "grown-up progeria is an uncommon, autosomal latent progeroid Syndrome (PS), which is described by the presence of untimely maturing.

Track: 11 Anti Cancer Drugs and Pharmacotherapeutics

Anticancer medications are utilized to treat malignancies, or dangerous developments. Drug treatment might be utilized alone, or in mix with different medicines, for example, surgery or radiation treatment Anti-malignancy medications are utilized to control the development of carcinogenic cells. Malignancy is normally characterized as the uncontrolled development of cells, with loss of separation and ordinarily, with metastasis, spread of the growth to different tissues and organs. Tumors are threatening developments. Interestingly, benevolent developments remain embodied and develop inside a very much characterized region. Albeit kind tumors might be lethal if untreated, because of weight on key organs, as on account of an amiable mind tumor, surgery or radiation are the favored techniques for treating developments which have a very much characterized area. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.

- Targeted Anticancer Therapies

- Nanotechnology in cancer drugs

- Anticancer drugs in global market: economy & their cost effectiveness

- Novel drug delivery system & cancer drug designing

- Therapeutic antibodies & cancer vaccines

- Drugs and mechanism

- Preventive Oncology Vaccines

- Preventive Oncology Drugs

- Preventive Oncology Stem Cell Therapy

- Preventive Oncology Pharmacology

- Modern medicine

- Gene Therapy

- Radiation Therapy

- Chemotherapy

- Cancer Therapy and Clinical Cancer Research

- Anti-cancer drugs and delivery

- Anti-Cancer Agents in Medicinal Chemistry

- Functional genomics in drug discovery & development

Track: 4 Organ Specific Cancer

Metastasis is a pathogenic specialist's spread from an initial or primary site to a different or secondary site within the host's body, yet is commonly talked about accordingly spread by a harmful tumor. The recently obsessive destinations, at that point, are metastases (Mets). Cancer happens after cells are hereditarily changed to multiply quickly and inconclusively. This uncontrolled multiplication by mitosis delivers an essential heterogenetic tumor. The cells which constitute the tumor inevitably experience metaplasia, trailed by dysplasia then an aplasia, bringing about a harmful phenotype. This threat takes into consideration intrusion into the course, trailed by attack to a moment site for tumorigenesis. Bosom threat is ailment that makes from chest tissue. Prostate malady is the progression of tumor in the prostate, an organ in the male conceptive structure. Most prostate malignancies are direct creating; in any case, some grow by and large quickly. Malignancy of the lung, similar to all tumors, comes about because of a variation from the norm in the body's essential unit of life, the cell. Ordinarily, the body keeps up an arrangement of governing rules on cell development so cells partition to deliver new cells just when new cells are required. The fundamental driver of melanoma is splendid light (UV) introduction in those with low levels of skin shade. A growth of blood-framing tissues, obstructing the body's capacity to battle contamination. A tumor that starts in the lungs and regularly happens in individuals who smoke. A disease of the colon or rectum, situated at the lower end of the stomach related tract.

Breast cancer - A cancer that forms in the cells of the breasts.

Prostate cancer - A cancer in a man's prostate, a small walnut-shaped gland that produces seminal fluid.

Basal cell cancer - A type of skin cancer that begins in the basal cells. • Melanoma - The most serious type of skin cancer.

Colon cancer - A cancer of the colon or rectum, located at the lower end of the digestive tract.

Lung cancer - A cancer that begins in the lungs and most often occurs in people who smoke.

Leukemia - A cancer of blood-forming tissues, hindering the body's ability to fight infection.

Track: 5 Cancer Biology

Cancer frameworks science includes the utilization of frameworks science ways to deal with tumor inquire about, keeping in mind the end goal to ponder the illness as a complex versatile framework with rising properties at different natural scales. All the more unequivocally, in light of the fact that growth traverses numerous organic, spatial and transient scales, correspondence and input instruments over the scales make a profoundly complex dynamic framework. The connections between scales are not basic or fundamentally immediate, and now and again wind up noticeably combinatorial, so frameworks approaches are basic to assess these connections quantitatively and subjectively. Malignancy frameworks science hence receives an all-encompassing perspective of growth went for incorporating its numerous organic scales, including hereditary qualities, flagging systems, epigenetics, cell conduct, histology, (pre)clinical indications and the study of disease transmission.

- Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics
- Microbes Meet Cancer
- Research on Causes of Cancer
- NCI's Role in Cancer Biology Research
- Opportunities in Cancer Biology Research
- Statistical and mechanistic modelling of cancer progression and development
- Cancer therapeutic resistance
- Cancer 'vaccine' eliminates tumors in mice
- Cancer Genomics

Track: 6 Cancer Stem Cells

Threat undifferentiated creatures are cancer cells that have characteristics associated with common juvenile microorganisms, especially the ability to offer climb to all cell sorts found in a particular development test. Malignancy Stem Cells are along these lines tumorigenic, possibly instead of other non-tumorigenic development cells. Malignancy Stem Cells may make tumors through the undifferentiated living being methods of self-energizing and division into various cell sorts. Such cells are speculated to hang on in tumors as specific masses and cause fall away from the faith and metastasis by offering climb to new tumors. In this way, progression of specific medications centered at CSCs holds look for after difference in survival and individual fulfillment of development patients, especially for patients with metastatic disease.

Track: 7 Cancer Causes and Diagnosis

Cancer is caused by (changes) to the DNA inside cells. The DNA inside a cell is packaged into incalculable qualities, each of which contains a plan of rules exhorting the cell what abilities to perform, and furthermore how to create and disengage. Botches in the ways can influence the cell to stop its common limit and may empower a cell to twist up clearly damaging. Threat chance components consolidate prologue to chemicals or distinctive substances, and also certain practices. They moreover consolidate things, people can't control, like age and family history. A family history of particular tumors can be an indication of a possible procured danger issue. Sickness abhorrence is move made to cut down the threat of getting tumor. Logical testing consolidates into test and the structure to gets the consistence about the ailment. There are different sorts of tests to conclusion the advancement. Biopsy test is done to consider disease. In this test little measure of tissue taken to take a gander at the probability of malady. Endoscopy is a test in which expert implants an endoscope through somewhat cut, or an opening in the body, The Cancer Diagnostics Market incorporates diverse parts of treatment. It is divided on the start Technology, Application and Region. In light of Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy, the tumor diagnostics business fragment is portrayed into arrange create and instrument-based with respect to the application, the risk diagnostics business part is isolated into lung disease, chest improvement, colorectal peril, melanoma, and others.

Track: 8 Preventive Oncology

Preventive oncology is any measure that is taken to prevent development or progression of malignant process. Around one third of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use, and one half of all cancer cases either arise from modifiable risk factors or can be detected as precursor lesions before the development of disease with metastatic potential. Prevention of cancer can take place on several different levels: primary prevention addresses the cause of cancer so disease does not occur, secondary prevention identifies disease before the onset of symptoms and keeps it from becoming more extensive, and tertiary prevention reduces complications and progression of disease once it has become clinically apparent.

- Public awareness and professional education
- Screening guidelines for cancer detection
- Clinical and laboratory aspects of cancer detection
- Management of early reparable neoplasms
- Novel therapeutic approaches
- Methodological issues of cancer detection

Track: 9 Cancer Biopsy

A Biopsy is the removal of a small amount of tissue or sample of cell from the body for examination under a microscope by a pathologist and can also be analyzed chemically. Other test like imaging are helpful in detecting area of abnormality, they can’t differentiate between Cancer cell and normal cell, only Biopsy perform definitive diagnosis of Cancer. The procedure of removing entire organ is called as excisional Biopsy and procedure of removing portion of abnormal tissue without attempting to remove the entire lesion or tissue is called as incisional Biopsy or core Biopsy. In some Biopsies, tumor samples are removed though a thin needle or through an endoscope. When the Cancer is diagnosed, a variety of Biopsy technique can be applied.

Track: 10 Treatments and Cancer Therapy

Cancer can be treated by different processes. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient). Many experimental cancer treatments are also under development. Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. You may also have immunotherapy, targeted therapy, or hormone therapy.

- Chemotherapy: Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. Learn how chemotherapy works against cancer, why it causes side effects, and how it is used with other cancer treatments.

- Hormone Therapy: Hormone therapy is a treatment that slows or stops the growth of breast and prostate cancers that use hormones to grow. Learn about the types of hormone therapy and side effects that may happen.

Precision Medicine: Precision medicine helps doctors select treatments that are most likely to help patients based on a genetic understanding of their disease. Learn about the role precision medicine plays in cancer treatment, including how genetic changes in a person's cancer are identified and used to select treatments.

Track: 11 Anti Cancer Drugs and Pharmacotherapeutics

Anticancer medications are utilized to treat malignancies, or dangerous developments. Drug treatment might be utilized alone, or in mix with different medicines, for example, surgery or radiation treatment Anti-malignancy medications are utilized to control the development of carcinogenic cells. Malignancy is normally characterized as the uncontrolled development of cells, with loss of separation and ordinarily, with metastasis, spread of the growth to different tissues and organs. Tumors are threatening developments. Interestingly, benevolent developments remain embodied and develop inside a very much characterized region. Albeit kind tumors might be lethal if untreated, because of weight on key organs, as on account of an amiable mind tumor, surgery or radiation are the favored techniques for treating developments which have a very much characterized area. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.

- Targeted Anticancer Therapies

- Nanotechnology in cancer drugs

- Anticancer drugs in global market: economy & their cost effectiveness

- Novel drug delivery system & cancer drug designing

- Therapeutic antibodies & cancer vaccines

- Drugs and mechanism

- Preventive Oncology Vaccines

- Preventive Oncology Drugs

- Preventive Oncology Stem Cell Therapy

- Preventive Oncology Pharmacology

- Modern medicine

- Gene Therapy

- Radiation Therapy

- Chemotherapy

- Cancer Therapy and Clinical Cancer Research

- Anti-cancer drugs and delivery

- Anti-Cancer Agents in Medicinal Chemistry

- Functional genomics in drug discovery & development

Track: 12 Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. The Radiotherapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Tele-radiotherapy, also called as External transcutaneous / distant radiotherapy, is a method in which the radiation source is situated at a certain distance from the tissue to be treated. Brachytherapy, also termed as Short direct radiotherapy / Curitherapy, is a method in which radiation source can be placed in contact with the tumor or it can be implanted in the tumor. Curative radiotherapy is indicated to be used in: Sticker’s sarcoma, Mastocytomas with particular locations, such as ears, nose, extremities, eyelids; Nasal cavity adenocarcinoma and Anal gland adenocarcinoma. Stereotacticradiosurgery is a single-day procedure for treating small intracranial lesions. Metabolic radiotherapy represents the administration of isotopes or isotope carrying molecules that selectively concentrate in a certain tissue into which they enter as metabolites. For Example; iodine-131is used in treating Thyroid cancer; phosphorus-32 is used in treating Myeloproliferative disorders.

- Radiation Therapy

- Predictive Oncology

- Cancer Imaging

- Stem Cell Therapy

- Oncology Nursing

- Radiation therapy

- Stereotactic body radiation therapy (SBRT)

- Intensity Modulated Radiotherapy (IMRT)

- Intravascular brachytherapy

- Prostate Seed Implant

RELATED TOPICS

Adjuvant therapy, Barium Enema, Benign cancer, Biopsy, Bone marrow transplant, Breast MRI, Cell Signalling, Computed Tomography scan, Colposcopy, Carcinoma, Clinical trials, Chemoprevention, Chemotherapy, Digital rectal exam, Drug development, Fibroid, Gene Therapy, Hormone therapy, Imaging tests, Carcinoma In situ, Invasive cancer, Integrative medicine, Immunotherapy, Leukemia, Localized cancer, Lymphatic system, MUGA scan, Mamography, Malignant cancer, Metastasis, Mastectomy, Neoadjuvant therapy, Oncology, PET-CT Scan, Pap test, Polyp, PSA test, Pre- malignant, Primary cancer, Palliative care, Placebo, Radiation therapy, Sarcoma, Screening, Secondary cancer, Tumor marker tests, Tumor, Targeted treatment, Tumor genetics.

Abstract submission deadline (1st round)
15 January 2019

Notification of acceptance or rejection of abstract
03-10 working days from the date of submission

Final presentation should be submitted

15 days before the conference date

Early bird registration

30 January 2019

MARKET ANALYSIS

The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Global Oncology / Cancer diagnostics market is expected to garner $13.1 billion by 2020, from an estimate of $7.1 billion in 2015, registering a CAGR of 12.9% during the forecast period 2014 to 2020. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Immunotherapy, Artificial intelligence, Molecular cancer diagnostics, etc are emerging as potential therapies to find the permanent cure for various cancer types. Global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.

CONFERENCE HIGHLIGHTS

"Latest Development and Novel Treatment for Cancer" will explore the fields of  Cancer Immunology & Vaccines, Cancer Screening & Diagnosis, Innovations in prevention and screening, Biomarkers, Leukemia, health professional cancers, Organ Specific Cancers, Childhood cancer, Anti-Cancer Drug Discovery & Therapy, Industrial cancer, Non-Hodgkin Lymphoma, Head and Neck Cancer, Gilomas, Kidney Cancer, Soft Tissue Sarcoma, AIDS-Related Cancer and etc..
prominent speakers from the industry with prodigious experiences.
leading professionals of the industry with valuable skills.
Emerging researchers in the respective field.
You will have a great opportunity to share your research concerns or challenges with the leading experts in the field.
You have an opportunity to raise your doubts and getting answers from the experts.

What is Cancer Care 2019 ?

The new science redefining cancer as a large number of narrowly defined diseases and yielding therapeutic options for an expanding number of patients is rapidly transforming the oncology treatment landscape.

Most health systems are struggling to adapt and embrace this evolution—including the regulatory systems, skilled professionals, diagnostic and treatment infrastructures, and financing mechanisms that are required to serve the needs of cancer patients around the world. These challenges demand urgent attention in light of the strong near-term pipeline of clinically distinctive therapies, and new programs.

The surge of innovation in cancer treatments is catching the attention of health system stakeholders and participants around the world. Providers and patients have more choices – and face more complexity - in treatment options, including the possibility of dramatic increases in progression free and overall survival. Payers are also noticing the impact on drug budgets of longer treatment duration and increased numbers of patients receiving treatment. The focus of the second series of this conference would address these factors.

Who to attend Cancer Care 2019?

Dean, Department heads, Professors, Associate Professors, Assistant Professors, PhD Scholars, Graduates, Post Graduates, Junior/Senior Research Fellows and Scientists with a background in oncology related spectrum of study. Anesthesiologist, case manager, dermatologist, registered dietitian, Doctor of osteopathic medicine, dosimetrist, endocrinologist, enterostomal therapist, gastroenterologist , genetic counselor, gynecologic oncologist, hematologist , oncology clinical nurse specialist , medical oncologist , neonatologist, occupational therapist, oncologist, oncology social worker, otolaryngologist , pain specialists, palliative care specialists, pathologist, pediatric oncologist, psychologist, pulmonologist, radiation oncologist, radiation therapist, respiratory therapist, surgical oncologist, thoracic surgeons. Industrial specialists, CEOs, project heads of pharmaceutical companies, clinical trial R&D members, professionals of radiology, imaging, etc equipment industries.

Why to attend Cancer Care 2019 ?

☛ Every professional who wishes to be a part of the highest level of research and science should share and discuss her/his results and findings in a broad scientific spectrum.
☛ The best opportunity to do that is to attend scientific conferences, which enables one to get opinions and advice and to gain knowledge.
☛ Cancer care conference offers opportunities for making connections.
☛ This conference is a great way to learn about clinical trials, new treatments, and research into which of the old treatments still work best.
☛ This conference is a platform for industry solution providers and seekers are some of the best people for you to get to know, if you want to learn more about the current business climate.
☛ Discovering innovative products and services for your business is necessary to stay competitive in today’s fast-paced world.